Skip to content
★ Sign in to follow
TP

Tai Phan

Karo Pharma AB
Total declarations
17
Company
1
▲ Purchases (5 ops.)
€138k
▼ Sales (0 ops.)
—

Latest filing published 04 Jun 2018 for Karo Pharma AB, €3,667.

Filing timeline

BuySale
Tai Phan

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Tai Phan: trading record in brief

Tai Phan discloses dealings in Karo Pharma AB to Finansinspektionen. Between 30 August 2017 and 1 June 2018, the trades on record add up to 17 filings.

Every open-market trade on record is a purchase: 5 purchases worth €138k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2018 to date brings 2 purchases and no sales.

A typical purchase (the median) is worth €5,747. Of 5 purchases, 3 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

On 4 June 2018 came the latest disclosure, a transaction for €3,667 in Karo Pharma AB. The latest purchase dates back some time: it was published 3,092 days ago, on 22 May 2018. The median gap between a trade and its publication by Finansinspektionen is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Tai Phan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total
  • ●
    MarknadschefExecutivesKaro Pharma AB
    37,800 SEK2FI-SE
    1,575 shares@ SEK 24.000.0% of flowISIN SE0007464888FI:csv-8d62560befaca17abe79
  • ●
    MarknadschefExecutivesKaro Pharma AB
    97,560 SEK2FI-SE
    4,065 shares@ SEK 24.000.0% of flowISIN SE0007464888FI:csv-f94302f6ce69486f437c
  • ●
    MarknadschefExecutivesKaro Pharma AB
    727,104 SEK2FI-SE
    30,296 shares@ SEK 24.000.0% of flowISIN SE0007464888FI:csv-46b855a0095b48e57ceb
  • ●
    MarknadschefExecutivesKaro Pharma AB
    2M SEK2FI-SE
    78,190 shares@ SEK 24.000.0% of flowISIN SE0007464888FI:csv-52fb3a5425416074e7eb
  • ▲
    MarknadschefExecutivesKaro Pharma AB
    59,245 SEK2FI-SE
    85,000 shares@ SEK 0.6970.0% of flowISIN SE0011204809FI:csv-551cc26fbb7620bf2ac6
    Canonical exit: 16 Aug 2018 (T+90)
  • ▲
    MarknadschefExecutivesKaro Pharma AB
    25,291 SEK2FI-SE
    30,001 shares@ SEK 0.8430.0% of flowISIN SE0011204809FI:csv-e2e22e8cee221bd22644
    Canonical exit: 19 Aug 2018 (T+90)
  • ●
    MarknadschefExecutivesKaro Pharma AB
    0FI-SE
    1,380 shares0FI:csv-662fceb83c1fbf4dbbbf
  • ●
    MarknadschefExecutivesKaro Pharma AB
    0FI-SE
    591 shares0FI:csv-b23481171d5a764e95af
  • ●
    MarknadschefExecutivesKaro Pharma AB
    0FI-SE
    1,380 shares0ISIN SE0007464888FI:csv-5a96ba69989ef5459b9f
  • ●
    MarknadschefExecutivesKaro Pharma AB
    0FI-SE
    591 shares0ISIN SE0007464888FI:csv-592cf7d1a7d805d0acb3
  • ●
    MarknadschefExecutivesKaro Pharma AB
    40,020 SEK2FI-SE
    1,380 shares@ SEK 29.000.0% of flowFI:csv-84adbb0fde5353471604
  • ●
    MarknadschefExecutivesKaro Pharma AB
    17,139 SEK2FI-SE
    591 shares@ SEK 29.000.0% of flowFI:csv-ecac170d059b744be086
  • ●
    MarknadschefExecutivesKaro Pharma AB
    1M SEK2FI-SE
    35,000 shares@ SEK 29.000.0% of flowISIN SE0010663039FI:csv-e9cdc69ac962edae8312
  • ●
    MarknadschefExecutivesKaro Pharma AB
    435,000 SEK2FI-SE
    15,000 shares@ SEK 29.000.0% of flowISIN SE0010663039FI:csv-34fedeaccf24bea6a30a
  • ▲
    MarknadschefExecutivesKaro Pharma AB
    49,500 SEK17FI-SE
    30,000 shares@ SEK 1.650.0% of flowISIN SE0010663021FI:csv-46161504f74503b89d01
    Canonical exit: 15 Mar 2018 (T+90)
  • ▲
    MarknadschefExecutivesKaro Pharma AB
    117,600 SEK17FI-SE
    70,000 shares@ SEK 1.680.0% of flowISIN SE0010663021FI:csv-9613486ad7ae91a89f5b
    Canonical exit: 15 Mar 2018 (T+90)
  • ▲
    MarknadschefExecutivesKaro Pharma AB
    1M SEK16FI-SE
    30,000 shares@ SEK 35.8020.4% of flowISIN SE0007464888FI:csv-92f1f97083a078548693
    Canonical exit: 28 Nov 2017 (T+90)

17 of 17 declarations